158 related articles for article (PubMed ID: 10710133)
1. The inhibitory effect of KT3-671, a nonpeptide angiotensin-receptor antagonist, on rabbit and rat isolate vascular smooth muscles: a possible involvement of K(ATP) channels.
Satake N; Imanishi M; Keto Y; Ishikawa M; Yamada H; Shibata S; Tomiyama A
J Cardiovasc Pharmacol; 2000 Mar; 35(3):457-67. PubMed ID: 10710133
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
[TBL] [Abstract][Full Text] [Related]
4. Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.
Panek RL; Lu GH; Overhiser RW; Major TC; Hodges JC; Taylor DG
J Pharmacol Exp Ther; 1995 May; 273(2):753-61. PubMed ID: 7752078
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of dithiothreitol on angiotensin II-induced contractions mediated by AT1-receptors in rat portal vein and rabbit aorta.
Zhang JS; van Meel JC; Pfaffendorf M; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):538-42. PubMed ID: 8065468
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta.
Takata Y; Tajima S; Kato H
Pharmacol Res; 2000 Mar; 41(3):335-40. PubMed ID: 10675286
[TBL] [Abstract][Full Text] [Related]
9. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
[TBL] [Abstract][Full Text] [Related]
10. Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.
Zhang JS; Van Meel JC; Pfaffendorf M; Van Zwieten PA
J Pharmacol Exp Ther; 1994 May; 269(2):509-14. PubMed ID: 8182519
[TBL] [Abstract][Full Text] [Related]
11. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Caussade F; Virone-Oddos A; Delchambre C; Cazes M; Versigny A; Cloarec A
Fundam Clin Pharmacol; 1995; 9(2):119-28. PubMed ID: 7628824
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.
Zerrouk A; Auguet M; Delaflotte S; Chabrier PE
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):466-73. PubMed ID: 8897450
[TBL] [Abstract][Full Text] [Related]
14. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
Ojima M; Inada Y; Shibouta Y; Wada T; Sanada T; Kubo K; Nishikawa K
Eur J Pharmacol; 1997 Jan; 319(1):137-46. PubMed ID: 9030909
[TBL] [Abstract][Full Text] [Related]
15. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
17. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
18. Functional and binding studies of insurmountable antagonism of 606A, a novel AT1-receptor antagonist in rabbit tissues.
Kurosawa Y; Minami K; Hashimoto Y; Narita H
J Cardiovasc Pharmacol; 1999 Jul; 34(1):132-8. PubMed ID: 10413079
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II 1 receptor-mediated contraction of pulmonary artery and its modulation by prolylcarboxypeptidase.
Tamaoki J; Sugimoto F; Tagaya E; Isono K; Chiyotani A; Konno K
J Appl Physiol (1985); 1994 Apr; 76(4):1439-44. PubMed ID: 8045817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
